Akari Therapeutics Plc (AKTX)
0.2592
0.00 (0.00%)
USD |
NASDAQ |
Feb 26, 16:00
0.2548
0.00 (0.00%)
After-Hours: 07:22
Akari Therapeutics Cash from Financing (TTM) : 9.592M for Sept. 30, 2025
Cash from Financing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| DBV Technologies SA | 118.28M |
| Cellectis SA | -9.029M |
| Biodexa Pharmaceuticals Plc | 12.98M |
| NuCana Plc | 36.12M |
| Autolus Therapeutics Plc | 27.46M |